Skip to main content
. Author manuscript; available in PMC: 2021 Feb 15.
Published in final edited form as: Pharmacol Ther. 2019 Feb 10;198:90–108. doi: 10.1016/j.pharmthera.2019.02.005

Table 3.

Receptor binding assays of intact and cleaved GLP-1 to GLP-1R

Intact GLP-1(7–36) Cleaved GLP-1(9–36) Ref.
Saturation binding assay KD 1.29 ± 0.26 AU 0.214 ± 0.08 AU Kuc et al. (2014)
Saturation binding assay BMAX 57.0 ± 14.5 AU 2.69 ± 0.74 AU Kuc et al. (2014)
SPA binding assay Ki 0.102 nM 156 nM Kuc et al. (2014)
cAMP assay EC50 0.072 nM 7270 nM Kuc et al. (2014)
cAMP assay EMAX 104% 8.93% Kuc et al. (2014)